A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis

enthalten in: Hepatology | 2017

von Tandon, P. | Reddy, K. | O'Leary, J. | +11

The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

enthalten in: Hepatology | 2016

von Bajaj, J. | Reddy, K. | Tandon, P. | +11

Variations in albumin use in patients with cirrhosis: An AASLD members survey

enthalten in: Hepatology | 2015

von Bajaj, J. | O'Leary, J. | Wong, F. | +1

Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis

enthalten in: Hepatology | 2014

von Wong, F. | Murray, P.

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures

enthalten in: Hepatology | 2014

von Bajaj, J. | O'Leary, J. | Reddy, K. | +10

Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience

enthalten in: Hepatology | 2012

von Bajaj, J. | O'Leary, J. | Reddy, K. | +6

Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndromeFNR HREF="fn1">FN ID="fn1">Potential conflict of interest: Nothing to report.FNR HREF="fn2">FN ID="fn2">Part of this work was undertaken at University College London Hospitals-University College London, which received a proportion of its funding from the United Kingdom Department of Health through the National Institute for Health Research Biomedical Research Centres. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health.

enthalten in: Hepatology | 2008

von Wong, F. | Moore, K. | Dingemanse, J. | +1

Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trialClinical Trial Registration Number: NCT00501722.

enthalten in: Hepatology | 2008

von Ginès, P. | Wong, F. | Watson, H. | +3

The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis. Potential conflict of interest: Nothing to report.

enthalten in: Hepatology | 2006

von Therapondos, G. | Hol, L. | Benjaminov, F. | +1

Hyponatremia in cirrhosis: Results of a patient population surveyFNR HREF="fn1">FN ID="fn1">Potential conflict of interest: Dr. Ginès is a consultant for and received grants from Sanofi-Aventis. Dr. Wong is a consultant for Sanofi-Aventis.

enthalten in: Hepatology | 2006

von Angeli, P. | Wong, F. | Watson, H. | +1